Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study

Ohad Atia, Eric I. Benchimol, Natan Ledderman, Shira Greenfeld, Revital Kariv, Yiska Loewenberg Weisband, Eran Matz, Jacob Ollech, Iris Dotan, Amit Assa, Dror S. Shouval, Holm H. Uhlig, Aleixo M. Muise, Ola Olén, M. Ellen Kuenzig, Gilaad G. Kaplan, Dan Turner*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Background & Aims: In this nationwide study from the Israeli Inflammatory Bowel Disease Research Nucleus, we aimed to describe the incidence of very early onset inflammatory bowel diseases (VEOIBDs) with a focus on infantile-onset disease and to compare management and disease course with older children. Methods: Data were retrieved from the 4 Israeli Health Maintenance Organizations covering 98% of the population. Pediatric-onset IBD was categorized as follows: adolescent onset (10 to <18 y), early onset (6 to <10 y), VEOIBD (0 to <6 y), toddler onset (2 to <6 y), and infantile onset (<2 y). Results: A total of 5243 children with 35,469 person-years of follow-up evaluation, were diagnosed with IBD during 2005 to 2020: 4444 (85%) with adolescent onset, 548 (10%) with early onset, and 251 (4.8%) with VEOIBD, of whom 81 (1.5%) had infantile onset. The incidence of pediatric-onset IBD increased from 10.8 per 100,000 in 2005 to 15.3 per 100,000 in 2019 (average annual percentage change, 2.8%; 95% CI, 2.2%–3.4%), but that of VEOIBD remained stable (average annual percentage change, 0%; 95% CI, -2.5% to 2.6%). The infantile-onset and toddler-onset groups were treated less often with biologics (36% and 35%, respectively) vs the early onset (57%) and adolescent-onset groups (53%; P <.001). The time to steroid dependency was shorter in infantile-onset (hazard ratio [HR], 2.1; 95% CI, 1.5–2.9) and toddler-onset disease (HR, 1.6; 95% CI, 1.2–2.0) vs early onset and adolescent-onset disease, but time to hospitalizations, time to surgery, and growth delay were worse only in infantile-onset disease. In a multivariable model, infantile-onset patients had a higher risk for surgery (HR, 1.4; 95% CI, 1.1–1.9) and hospitalization (HR, 1.7; 95% CI, 1.2–2.4) than the toddler-onset group. Conclusions: The incidence of VEOIBD remained stable. Infantile-onset IBD had worse outcomes than older children, while toddler onset had mostly similar outcomes, despite less frequent use of biologics.

Original languageAmerican English
Pages (from-to)2639-2648.e6
JournalClinical Gastroenterology and Hepatology
Volume21
Issue number10
DOIs
StatePublished - Sep 2023

Bibliographical note

Publisher Copyright:
© 2023 AGA Institute

Keywords

  • IBD
  • Outcomes
  • Very Early Onset

Fingerprint

Dive into the research topics of 'Incidence, Management, and Outcomes of Very Early Onset Inflammatory Bowel Diseases and Infantile-Onset Disease: An Epi-IIRN Study'. Together they form a unique fingerprint.

Cite this